Cambridge Investment Research Advisors’s Gildan GIL Stock Holding History

Cambridge Investment Research Advisors’s Portfolio GIL Stock Details GIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$245K	Sell	4,752 -1,413	-23%	-$81.1K	﹤0.01%	3624
2026 Q1	$343K	Sell	6,165 -736	-11%	-$47.6K	﹤0.01%	3162
2025 Q4	$431K	Buy	+6,901	New	+$410K	﹤0.01%	2865
2024 Q3	–	Sell	-9,814	Closed	-$372K	–	3459
2024 Q2	$372K	Sell	9,814 -263	-3%	-$9.51K	﹤0.01%	2535
2024 Q1	$374K	Sell	10,077 -685	-6%	-$23.3K	﹤0.01%	2528
2023 Q4	$356K	Buy	+10,762	New	+$349K	﹤0.01%	2467
2017 Q1	–	Sell	-11,767	Closed	-$299K	–	1783
2016 Q4	$299K	Sell	11,767 -504	-4%	-$13.4K	0.01%	1269
2016 Q3	$343K	Sell	12,271 -774	-6%	-$22.9K	0.01%	1227
2016 Q2	$383K	Buy	13,045 +1,871	+17%	+$55.8K	0.01%	1070
2016 Q1	$341K	Buy	+11,174	New	+$297K	0.01%	1105
2015 Q3	–	Sell	-15,813	Closed	-$526K	–	1522
2015 Q2	$526K	Buy	+15,813	New	+$507K	0.01%	791

Other funds holding GIL

Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $70.2B AUM 30.95% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Cambridge Investment Research Advisors's GIL Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Gildan (GIL) stake by 23% in Q2 2026, selling an estimated $81.1K and leaving 4,752 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #3624.

Cambridge Investment Research Advisors first reported a position in GIL in Q2 2015 and has held it in 11 quarters since. The position peaked at $526K in Q2 2015. 464 funds tracked by Wall St. Rank hold GIL as of Q2 2026.

Cambridge Investment Research Advisors held 4,752 shares of Gildan worth $245K as of Q2 2026.
Cambridge Investment Research Advisors sold 1,413 Gildan shares in Q2 2026, an estimated $81.1K.
Gildan made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3624 holding.
Cambridge Investment Research Advisors first reported a position in Gildan in Q2 2015 and has held it in 11 quarters since.
Cambridge Investment Research Advisors's Gildan position peaked at $526K in Q2 2015.
464 funds tracked by Wall St. Rank held Gildan as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.